Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 330 of 5804
-
Can a shorter steroid course save preemie lungs?
Prevention Not yet recruitingThe goal of this clinical trial is to compare the effectiveness of two different dexamethasone treatment regimens (the DART regimen and the medium-dose tapering regimen) in reducing the incidence of Bronchopulmonary Dysplasia (BPD) or death by 36 weeks of postmenstrual age in pre…
Phase: PHASE3 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Could laughing gas lift the fog of depression?
Symptom relief Not yet recruitingMulti-centre, parallel group, blinded, 1:1 randomized controlled trial to determine the effect of nitrous oxide on reducing symptoms of depression in patients with treatment resistant depression.
Phase: PHASE3 • Sponsor: Women's College Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New CPR technique could boost survival after cardiac arrest
Disease control Not yet recruitingBio-CPR is an innovative new mechanical resuscitation model proposed by our research group. A multi-center RCT study was established to comprehensively evaluate the efficacy of this model and the current standard CPR protocol, verify its safety and efficacy, and provide high-qual…
Phase: NA • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Cancer cocktail aims to turn inoperable tumors into surgical wins
Disease control Not yet recruitingThe primary objective is to evaluate the efficacy and safety of Iparomlimab and Tuvonralimab Injection (QL1706, an Anti-PD-1/CTLA-4 Combined Antibody) combined with GemOX and lenvatinib as conversion therapy for Initially Potentially Resectable intrahepatic cholangiocarcinoma and…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New hope for advanced liver cancer: drug trial targets patients with limited options
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of lenvatinib as first-line therapy in patients with Child-Pugh class B HCC who are unsuitable for curative treatment.
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could a daily brain zapping helmet ease autism symptoms in kids?
Symptom relief Not yet recruitingThis study will test whether a noninvasive brain stimulation treatment called Functional Neurogenesis Stimulation (using the NeuroCytontron device) can safely improve core symptoms of Autism Spectrum Disorder (ASD) in children. The study will enroll boys and girls 3 to 12 years o…
Phase: NA • Sponsor: Neurocytonix, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New drug aims to save lives from shock due to blood loss
Disease control Not yet recruitingThis protocol is designed to develop a novel first-in-class treatment for use in critical care and life-threatening condition of hypovolemic shock with unmet need and is of national interest. Shock is a life-threatening condition of circulatory failure. It is a state of cellular …
Phase: PHASE3 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Immunotherapy plus chemo shows promise in shrinking HPV throat tumors before surgery
Disease control Recruiting nowThis is a single-center phase 2 study of to test how well the combination of toripalimab with chemotherapy followed by TORS or risk and response stratified de-escalated (chemo)radiotherapy works in patients with in HPV16+ locoregionally advanced oropharyngeal cancer (OPC).
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Robots vs. laparoscopy: which surgery beats stomach cancer?
Disease control Not yet recruitingThe goal of this multicenter, randomized, phase III clinical trial is to test whether robot-assisted radical gastrectomy improves 3-year recurrence-free survival versus laparoscopy-assisted radical gastrectomy in adults aged 18-80 years with previously untreated, resectable cT4a …
Phase: PHASE3 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New Three-Drug cocktail aims to tackle Hard-to-Treat multiple myeloma
Disease control Not yet recruitingDespite advances in multiple myeloma (MM) therapy, patients continue to suffer from frequent relapses and treatment-resistant disease. Therefore, additional novel, safe, and effective therapies are needed to drive deeper and more prolonged responses for patients with RRMM. Mezig…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for lymphoma patients: experimental drug combo enters final trial phase
Disease control Not yet recruitingThis study is a randomized, controlled, double-blind, multicenter, phase III clinical study to evaluate the efficacy of IMM0306 (Amulirafusp Alfa)in combination with lenalidomide versus placebo in combination with lenalidomide in patients with Relapsed/Refractory Follicular lymph…
Phase: PHASE3 • Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a common antiviral save lives in advanced HIV?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if valganciclovir works to treat cytomegalovirus (CMV) infection in people with advanced HIV disease. It will also look at the safety of valganciclovir and how the body handles the drug. The main questions this study aims to answer are…
Phase: PHASE2 • Sponsor: Wits Health Consortium (Pty) Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New breathing support could save tiny lungs
Disease control Not yet recruitingRespiratory Distress Syndrome (RDS) remains the most common respiratory complication in the early postnatal period among preterm infants born before 32 weeks' gestational age. For this population, implementing lung-protective ventilation strategies is essential to shorten the dur…
Phase: NA • Sponsor: Xingwang Zhu • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Heated chemo during surgery may fight chest tumor spread
Disease control Not yet recruitingHyperthermic intrathoracic chemotherapy (HITOC) offers a strategy to eliminate microscopic residual disease after surgical resection. Especially it is investigated to improve long-term survival in thymic epithelial tumors with pleural dissemination or recurrence. A prospective, m…
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New combo aims to tackle tough rectal cancer
Disease control Not yet recruitingResearch objective: To compare the efficacy and safety of Capox + Bev versus Capox + Bev combined with primary site radiotherapy + (Iparomlimab and Tuvonralimab) as the first-line treatment for RAS Mutation/pMMR metastatic rectal cancer patients. Study endpoint: Primary endpoin…
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug cocktail aims to stop rare blood cancer after transplant
Disease control Recruiting nowThis study is a single-center, single-arm, prospective, phase II clinical trial designed to evaluate the efficacy and safety of Cidabenamine combined with Azacitidine as maintenance therapy following allogeneic peripheral blood hematopoietic stem cell transplantation in patients …
Phase: PHASE2, PHASE3 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Lung cancer trial aims to boost tumor shrinkage while protecting lungs
Disease control Not yet recruitingMoving immunotherapy ahead of chemoradiotherapy in a "sandwich" model-where tumor reduction is achieved through induction chemo-immunotherapy, immunotherapy is paused during chemoradiotherapy, and then resumed as maintenance post-radiotherapy-has shown promising potential. Howeve…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New study aims to cut Alzheimer's diagnosis wait time by nearly a year
Diagnosis Not yet recruitingThe BioMIND (Biomarkers for the Molecular Identification of Neurodegenerative Dementia) pilot study was launched at Parkwood Hospital in response to national calls for implementation of biomarker diagnostics in Canada. It evaluated the feasibility, impact, and equity of introduci…
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
New hope for NMOSD attacks: immune drug added to standard care
Disease control Recruiting nowThis project is a multi-center, prospective, real-world cohort study that collects clinical data of Chinese patients with AQP4-positive NMOSD in the acute stage. It comprehensively assesses the clinical outcomes of the patients and aims to compare the clinical efficacy and safety…
Phase: PHASE4 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Heart-Saving pills? diabetes drugs tested to shield breast cancer patients from chemo damage
Prevention Not yet recruitingBackground: Breast cancer is the most frequently diagnosed malignancy among women worldwide and a major cause of morbidity and mortality. Anthracycline-based chemotherapy, particularly doxorubicin, remains a cornerstone of treatment; however, its clinical utility is limited by d…
Phase: PHASE4 • Sponsor: Tanta University • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC